Oxygen is of vital importance for the metabolism and function of all cells in the human body. Hypoxia, the reduction of oxygen supply, results in adaptationally appropriate alterations in gene expression through the activation of hypoxia-inducible factor 1 (HIF-1) to overcome any shortage of oxygen. Thyroid hormones are required for normal function of nearly all tissues, with major effects on oxygen consumption and metabolic rate. Thyroid hormones have been found to augment the oxygen capacity of the blood by increasing the production of erythropoietin (EPO) and to improve perfusion by vasodilation through the augmented expression of adrenomedullin (ADM). Since the hypoxic expression of both genes depends on HIF-1, we studied the influence of thyroid hormone on HIF-1 activation in the human hepatoma cell line HepG2 under normoxic and hypoxic conditions. We found that thyroid hormones increased HIF-1α protein accumulation by increasing HIF-1α protein synthesis rather than attenuating its proteasomal degradation. HIF-1α expression directly correlated with augmented HIF-1 DNA binding and transcriptional activity of luciferase reporter plasmids, while HIF-1β levels remained unaffected. Knocking down HIF-1α by siRNA clearly demonstrated that thyroid hormone induced target gene expression required the presence of HIF-1. Although an increased association of the two known coactivators of HIF-1, p300 and SRC-1 was found, thyroid hormone did not affect the activity of the isolated C-terminal transactivating domain of HIF-1α. Increased synthesis of HIF-1α may contribute to the adaptive response of increased oxygen demand under hyperthyroid conditions.
Introduction
Erythropoietin (EPO), a 30.4 kDa glycoprotein hormone, is the major physiological stimulator of red blood cell formation in mammals (18) . The main EPO production sites are the kidney in adults and the liver in fetuses (6) . EPO production is induced by hypoxia, a state when oxygen supply does not cover the demand of the tissue. EPO mRNA levels are induced 50-to 100-fold in vitro by physiologically relevant levels of hypoxia (9) . In vivo under severe hypoxia, production of EPO can be increased up to 1,000-fold (18; 29) .
Oxygen dependent EPO expression is regulated by hypoxia-inducible factor 1 (HIF-1), a heterodimer of the O 2 -labile 120 kDa α-subunit and the constitutive 91 to 94 kDa ß-subunit (37) . The cellular levels of HIF-1α are adjusted by the ubiquitinproteasome -dependent degradation of HIF-1α under normoxic conditions allowing to tightly couple the protein appearance to the ambient oxygen tension (31) . At high PO 2 HIF-1α is posttranslationally hydroxylated at proline residues 402 and 564 by O 2 sensitive prolyl hydroxylases, termed PHD1, PHD2 and PHD3, which are today's recognized as the most likely cellular O 2 -sensors (7; 17) . Hydroxylated HIF-1α is recognized by the tumor suppressor von Hippel-Lindau (pVHL) protein for ubiquitination by the E3 ubiquitinprotein ligase (23) . Under hypoxia, HIF-1α evades proteasomal degradation because of the lack of proline hydroxylation, concomitantly accumulates and is translocated into the nucleus to form the HIF-1 complex by dimerization with constitutively expressed HIF-1ß (identical to aryl hydrocarbon receptor nuclear translocator 1, ARNT1) (14; 37) . Binding of HIF-1 to DNA at HIF-binding site (HBS) within the hypoxia response element (HRE) in the 3'-flanking EPO enhancer increases expression of the gene under hypoxic conditions (33) . In addition to hypoxic accumulation, the trans-activity of HIF-1α is regulated by the 
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O 2 -sensitive asparagyl-hydroxylase FIH-1 (factor inhibiting HIF-1) (22) . Under hypoxia the lack of hydroxylation of Asp803 allows binding of the adapter protein p300 to recruit further coactivator proteins like steroid receptor coactivator-1 (SRC-1) (3; 20) .
Like EPO the expression of adrenomedullin (ADM) a hypotensive peptide originally isolated from a pheochromocytoma is hypoxia inducible (4) . Promoter analysis revealed that this induction was primarily mediated by HIF-1 bound to regulatory DNA sequences within the promoter of rodent (4; 25) and human cells (12; 16) .
Thyroid hormone is required in nearly all tissues, with major effects on oxygen consumption and metabolic rate. Adaptation to this increased metabolic demand is partly achieved by potent effects of thyroid hormone on erythropoiesis and thus blood oxygen capacity. Thyroid hormones directly increase the proliferation of erythroid progenitors (5; 13) and thyroid hormone receptors were identified on nucleated erythroid cells isolated from hypoxic hamsters (1). Apart from the direct effect in erythroid precursors, thyroid hormone directly enhanced hypoxia-inducible EPO formation both in the isolated perfused rat kidney and HepG2 cells (10) . In addition, tissue perfusion may be increased through the stimulated expression of the potent vasodilator ADM by thyroid hormones (15; 25) .
The molecular mechanisms of thyroid hormone-inducible EPO and ADM expression have not yet been elucidated. Thyroid hormone binds to the intracellular thyroid hormone receptor (TR), a member of the nuclear hormone receptor family, which acts as a transcription factor and regulates gene expression (8) . Moreover, it has been reported that steroid receptor coactivator-1 (SRC-1) functions as a positive regulator of the TR-mediated transactivation pathway (19) . Thus, herein we studied whether thyroid hormones impinge on the HIF-1 activation pathway and by that means affect hypoxia-inducible expression of
Materials and Methods
Cell culture and in vitro stimulation. The human hepatoma cell line, HepG2 obtained from the American Type Culture Collection (ATCC HB 8065) was grown in RPMI 1640 supplemented with 10% fetal calf serum (FCS), penicillin (100U/ml) and streptomycin (100µg/ml) in a humidified atmosphere (5% CO 2 in air) at 37°C. Care was taken to avoid formation of cell clumps that would result in a heterogeneous distribution of the pericellular oxygen tension. To examine the effects of thyroid hormone, cells were regularly cultured serum-free in the RPMI 1640 medium containing 1% serum supplement (SS; transferrin, insulin, selenium, albumin; Sigma, Munich, Germany) for 24 hours before the experiment to remove the effects of serum-derived hormones. Transiently transfected HepG2 cells were kept in RPMI 1640 supplemented with 1% SS for 8 hours before the experiments.
At the beginning of an experiment, HepG2 cells received fresh medium (RPMI 1640 supplemented with 1% SS) containing the respective thyroid hormone concentration.
Triiodothyronine (T3) and thyroxine (T4; Sigma, Munich, Germany) stock solutions (14.86 mM in 1:4 1N HCl : ethanol for T3 and 56.2 mM in 4 N ammonium hydroxide in methanol for T4 were stored at -80ºC. To achieve hypoxic conditions, culture dishes were placed in a Heraeus incubator (Hanau, Germany) with 5% CO 2 , and nitrogen (N 2 ) to balance for different O 2 concentrations. Hypoxia was defined as 3% O 2 if not indicated otherwise. Control normoxic cells were placed in an incubator (5% CO 2 in air) for equivalent time periods. For reoxygenation experiments, cells were exposed to hypoxia for 4 hours and then transferred to 21% O 2 for different times. Nuclear extracts were prepared Agarose gel electrophoresis confirmed the specificity of the amplification product.
The resulting PCR fragments were visualized on ethidium bromide-stained 1.5% agarose gels. Tenfold dilutions of purified PCR products starting at 1pg to 0.1fg were used as standards. Amplification conditions were set to 10 minutes at 95°C followed by 45 PCR cycles (15 seconds at 95°C, 1 minute at 60°C). The quantity of cDNA used in each reaction was normalized to the ß-actin cDNA and expressed as cDNA/µg total RNA. anti-rabbit antibodies were used as a secondary antibody at a 1:10000 dilution in TBS-T containing 5% non-fat milk. Anti-α-tubulin antibody (at a 1:500 dilution, Santa Cruz) was used as a loading control. Immunoreative proteins were visualized using the enhanced chemiluminescence plus (ECL) detection system followed by exposure to X-ray film (Agfa, Mortsel, Belgium). antibody was added for supershift detection of the HIF-1 complex and incubated overnight at 4°C. The products were analyzed by electrophoresis in 5% non-denaturing polyacrylamide gels. Electrophoresis was performed at 80 volts in 0.25 x TBE buffer at 4°C for 4 hours. The dried gels were exposed to X-ray films and PhosphoImage sheets overnight.
Electrophoretic mobility shift assay (EMSA)
.
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Immunoprecipitation. 1mg of cell extract was incubated 2 hours at 4°C with 2.5µg of anti-Src-1 antibody (sc-6098, Santa Cruz) or anti-p300 (sc-584, Santa Cruz), followed by overnight incubation with 20µl of protein A-Sepharose beads (Santa Cruz) on a rotator at 4°C. Beads were washed five times with 1x TBS, denatured samples 4 x sample buffer at 95°C for 5 minutes. Beads were removed by centrifugation, and supernatants were loaded on 7.5% SDS-PAGE followed by Western blotting and detection with the anti-HIF-1α antibody as described above. 
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Heidelberg, Germany). Luciferase activity was expressed in relative light units (RLU) and normalized to total cellular protein measured by using the Bio-rad protein assay kit.
35 S-radioisotopic labelling. Cells, starved for 1 h in serum-and methionine-free medium (PromoCell, Heidelberg, Germany) were replaced with methionine-free medium containing 1% SS and 100 µCi/ml (Figure 2A) . In contrast, HIF-1β was constitutively present and expression remained unchanged by thyroid hormone treatment (Figure 2A) . In addition, 50 nM T3 had no effect on NFκB accumulation while HIF-1α levels were increased ( Figure 2B) . Interestingly, HepG2 cells displayed high levels of HIF-2α under normoxia, which were only marginally increased by hypoxia. In the same cells HIF-1α showed a strong hypoxic response. Nevertheless, 50 nM T3
increased HIF-1α accumulation but did not affect HIF-2α levels ( Figure 2B ).
Figure 2A and 2B
To test whether thyroid hormones affect transcription of the hif-1α gene the effect of thyroid hormones on HIF-1α mRNA levels was determined by RT-PCR. As shown in Figure 2C , HIF-1α mRNA levels remained constant, suggesting that thyroid hormone most likely induced HIF-1α protein expression via post-transcriptional regulation.
Thyroid hormones do not stabilize HIF-1α but increase its synthesis.
To elucidate posttranscriptional mechanisms we examined whether T3 would stabilize HIF-1α. Therefore, HepG2 cells were exposed to hypoxia for 4 hours and then returned to normoxia. Although T3 increased HIF-1α protein levels under hypoxia it did not affect HIF-1α degradation upon reoxygenation ( Figure 3A) . Upon the transition from hypoxia to reoxygenation HIF-1α completely disappeared within 30 min in control and T3 treated cells. When the destruction of HIF-1α was inhibited by the addition of MG132, an inhibitor of proteasomal degradation, T3 was still able to increase HIF-1α protein levels ( Figure 3B ). The addition of the translational inhibitor cycloheximide (CHX), however, prevented the T3-dependent increase of HIF-1α ( Figure 3C ). It is interesting to note that under conditions of 3 % O 2 in the incubation gas and a corresponding pericellular PO 2 of 5 to 7 mmHg HIF-1α was cleared from the cells when new synthesis is prevented by CHX.
Again, as shown above T3 did not increase the half-life of HIF-1α but CHX prevented the T3 induced increase in HIF-1α levels. Since these data indicated that T3 might elevate HIF-1α levels by increasing the rate of translation, 35 S-radioisotopic labelling of nascent HIF-1α protein was performed. In these experiments T3 clearly increased HIF-1α protein synthesis ( Figure 3D ).
Thyroid hormone increases the formation of a HBS bound complex containing

HIF-1α.
To test whether T3 also increased HIF-1 DNA binding, nuclear extracts from HepG2 cells treated with or without T3 in 3% O 2 for 6 hours were isolated for EMSA using a double-stranded oligonucleotide containing the HBS from the EPO 3' enhancer as a probe (Figure 4) . performed. For both co-activators increased amounts of complexes with HIF-1α were found ( Figure 6A) . However, when the activity of the C-TAD was determined T3 was without any effect although hypoxia increased the activity of the C-TAD significantly ( Figure 6B) . Thus, increased co-immunoprecipitation of HIF-1α with p300 and SRC-1 under T3 treatment probably reflects more input, i.e. HIF-1α loading rather than supporting the notion that the interaction between HIF-1α and p300 or SRC-1 was increased.
Figure 6 Discussion
Thyroid hormones exert a calorigenic effect on the tissue that increases the demand for oxygen. Therefore erythropoiesis, which provides the necessary oxygen capacity of the blood and the control of erythropoiesis by EPO have always been closely linked with the effects of thyroid hormones (2) . Most investigators understood increased serum levels of EPO in hyperthyroidism to be caused by a greater demand for oxygen in the tissue under the action of thyroid hormones. Increased oxygen consumption was thought to cause a sufficiently low pO 2 in the tissue to trigger the production of EPO (26) . However, there is no experimental evidence that the action of thyroid hormone on EPO production exclusively depends on an increase in oxygen consumption. In fact, some groups found a non-calorigenic effect of thyroid hormones on erythropoiesis when oxygen consumption was not closely correlated with the increase in radio-iron incorporation into red blood cells following the application of thyroid hormone (5; 27). A direct, non-calorigenic stimulation of EPO production in vitro was revealed by direct measurement of oxygen consumption in HepG2 cells (10) , and further supported by the experiment in which HepG2 cells were maintained in hypoxia due to diffusion-limited oxygen supply (24) . In this setting, thyroid hormones exerted their full stimulatory effect on EPO production even though the culture conditions prevented oxygen consumption dependent changes in the pO 2 (10).
The biological meaning of the effect of thyroid hormones on EPO production and erythropoiesis appears obvious due to the tight coupling of blood oxygen capacity and oxygen demand of the tissue. In contrast, the finding that T3 stimulates the expression of the hypotensive hormone ADM in vitro and in vivo (25) HepG2 cells were treated with T3 for 6 h under normoxic or hypoxic conditions.
Immunoprecipitation was performed using anti-SRC-1 and anti-p300 antibodies (IP).
Subsequently precipitates were subjected to Western blot and HIF-1α was detected by a monoclonal antibody (A). The two-hybrid GAL4-system was used to test for the activity of the CTAD (amino acids 775 to 826 of HIF-1α) which was fused in frame to the DNA binding domain of GAL4. GAL4-luciferase was co-transfected to determine the activity of the fusion protein (B). Shown are the means ± SD of 3 to 4 separate experiments with or without stimulation by T3 under normoxic and hypoxic conditions. # Indicates a significant difference between normoxic and hypoxic cultures (P < 0.001). 
